OMC
OUP Management Company Portfolio holdings
AUM
$44.5M
1-Year Est. Return
54.04%
1 Year Est. Return
+54.04%
AUM
$44.5M
AUM Growth
-$14.2M
(-24%)
Holding
13
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$3.09B
| $19M | 42.74% |
2,937,615
|
|
||
|
JBIO
2
Jade Biosciences
JBIO
$431M
| $8.19M | 18.43% |
17,250
|
|
||
|
CYT
3
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $6.99M | 15.71% |
2,459,572
|
|
||
4
PMV Pharmaceuticals
PMVP
$74.2M
| $6.07M | 13.66% |
989,232
|
|
||
|
LENZ
5
LENZ Therapeutics
LENZ
$1.16B
| $1.01M | 2.27% |
58,044
|
|
||
6
Cartesian Therapeutics
RNAC
$234M
| $914K | 2.06% |
28,751
|
|
||
7
Vor Biopharma
VOR
$199M
| $794K | 1.79% |
374,714
|
|
||
|
EFTR
8
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $615K | 1.38% |
41,028
|
|
||
9
Precision BioSciences
DTIL
$81.3M
| $384K | 0.86% |
37,464
|
|
||
10
Spero Therapeutics
SPRO
$124M
| $301K | 0.68% |
249,070
|
|
||
|
IMA
11
ImageneBio Inc
IMA
$84.3M
| $116K | 0.26% |
+2,236
|
|
||
12
Q32 Bio
QTTB
$38.7M
| $74.9K | 0.17% |
3,556
|
|
||
|
DICE
13
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – |
-268,346
|
|